Edwards Lifesciences's market cap is currently $39.24B. The company's EPS TTM is CHF0.5405392299; its P/E ratio is 34.28; Edwards Lifesciences is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is CHF0.50. See an overview of income statement, balance sheet, and cash flow financials.
